The wording of the Flaskworks PR leads me think they are attempting to time it “upon approval”, with the set backs in the timeline making that an easier objective…, but I most certainly could be wrong.
It takes BP years to complete that type of comparability assessment. This little company will take much longer. Maybe they can kick it out for DCVax D, when or if that goes phase 2?
News 
Market Data 
Discover 
